|
1
|
Owens GK, Kumar MS and Wamhoff BR:
Molecular regulation of vascular smooth muscle cell differentiation
in development and disease. Physiol Rev. 84:767–801. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rzucidlo EM: Signaling pathways regulating
vascular smooth muscle cell differentiation. Vascular. 17:(Suppl
1). S15–S20. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Moazed D: Small RNAs in transcriptional
gene silencing and genome defence. Nature. 457:413–420. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Krol J, Loedige I and Filipowicz W: The
widespread regulation of microRNA biogenesis, function and decay.
Nat Rev Genet. 11:597–610. 2010.PubMed/NCBI
|
|
5
|
Boettger T, Beetz N, Kostin S, Schneider
J, Krüger M, Hein L and Braun T: Acquisition of the contractile
phenotype by murine arterial smooth muscle cells depends on the
Mir143/145 gene cluster. J Clin Invest. 119:2634–2647. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cordes KR, Sheehy NT, White MP, Berry EC,
Morton SU, Muth AN, Lee TH, Miano JM, Ivey KN and Srivastava D:
miR-145 and miR-143 regulate smooth muscle cell fate and
plasticity. Nature. 460:705–710. 2009.PubMed/NCBI
|
|
7
|
Xin M, Small EM, Sutherland LB, Qi X,
McAnally J, Plato CF, Richardson JA, Bassel-Duby R and Olson EN:
MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and
responsiveness of smooth muscle cells to injury. Genes Dev.
23:2166–2178. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Deacon DC, Nevis KR, Cashman TJ, Zhou Y,
Zhao L, Washko D, Guner-Ataman B, Burns CG and Burns CE: The
miR-143-adducin3 pathway is essential for cardiac chamber
morphogenesis. Development. 137:1887–1896. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Quintavalle M, Elia L, Condorelli G and
Courtneidge SA: MicroRNA control of podosome formation in vascular
smooth muscle cells in vivo and in vitro. J Cell Biol. 189:13–22.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Davis BN, Hilyard AC, Nguyen PH, Lagna G
and Hata A: Induction of microRNA-221 by platelet-derived growth
factor signaling is critical for modulation of vascular smooth
muscle phenotype. J Biol Chem. 284:3728–3738. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu X, Cheng Y, Zhang S, Lin Y, Yang J and
Zhang C: A necessary role of miR-221 and miR-222 in vascular smooth
muscle cell proliferation and neointimal hyperplasia. Circ Res.
104:476–487. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ji R, Cheng Y, Yue J, Yang J, Liu X, Chen
H, Dean DB and Zhang C: MicroRNA expression signature and
antisense-mediated depletion reveal an essential role of MicroRNA
in vascular neointimal lesion formation. Circ Res. 100:1579–1588.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chan MC, Hilyard AC, Wu C, Davis BN, Hill
NS, Lal A, Lieberman J, Lagna G and Hata A: Molecular basis for
antagonism between PDGF and the TGFbeta family of signalling
pathways by control of miR-24 expression. EMBO J. 29:559–573. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Elia L, Quintavalle M, Zhang J, Contu R,
Cossu L, Latronico MV, Peterson KL, Indolfi C, Catalucci D, Chen J,
et al: The knockout of miR-143 and −145 alters smooth muscle cell
maintenance and vascular homeostasis in mice: Correlates with human
disease. Cell Death Differ. 16:1590–1598. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang C: MicroRNA-145 in vascular smooth
muscle cell biology: A new therapeutic target for vascular disease.
Cell Cycle. 8:3469–3473. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yu ML, Wang JF, Wang GK, You XH, Zhao XX,
Jing Q and Qin YW: Vascular smooth muscle cell proliferation is
influenced by let-7d microRNA and its interaction with KRAS. Circ
J. 75:703–709. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Louis WJ and Howes LG: Genealogy of the
spontaneously hypertensive rat and Wistar-Kyoto rat strains:
Implications for studies of inherited hypertension. J Cardiovasc
Pharmacol. 16:(Suppl 7). S1–S5. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Leeper NJ, Raiesdana A, Kojima Y, Chun HJ,
Azuma J, Maegdefessel L, Kundu RK, Quertermous T, Tsao PS and Spin
JM: MicroRNA-26a is a novel regulator of vascular smooth muscle
cell function. J Cell Physiol. 226:1035–1043. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xie C, Huang H, Sun X, Guo Y, Hamblin M,
Ritchie RP, Garcia-Barrio MT, Zhang J and Chen YE: MicroRNA-1
regulates smooth muscle cell differentiation by repressing
Kruppel-like factor 4. Stem Cells Dev. 20:205–210. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Villeneuve LM, Kato M, Reddy MA, Wang M,
Lanting L and Natarajan R: Enhanced levels of microRNA-125b in
vascular smooth muscle cells of diabetic db/db mice lead to
increased inflammatory gene expression by targeting the histone
methyltransferase Suv39h1. Diabetes. 59:2904–2915. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Small EM, Sutherland LB, Rajagopalan KN,
Wang S and Olson EN: MicroRNA-218 regulates vascular patterning by
modulation of Slit-Robo signaling. Circ Res. 107:1336–1344. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fichtlscherer S, De Rosa S, Fox H,
Schwietz T, Fischer A, Liebetrau C, Weber M, Hamm CW, Röxe T,
Müller-Ardogan M, et al: Circulating microRNAs in patients with
coronary artery disease. Circ Res. 107:677–684. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hermeking H: The miR-34 family in cancer
and apoptosis. Cell Death Differ. 17:193–199. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
He L, He X, Lim LP, de Stanchina E, Xuan
Z, Liang Y, Xue W, Zender L, Magnus J, Ridzon D, et al: A microRNA
component of the p53 tumour suppressor network. Nature.
447:1130–1134. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Choi YJ, Lin CP, Ho JJ, He X, Okada N, Bu
P, Zhong Y, Kim SY, Bennett MJ, Chen C, et al: miR-34 miRNAs
provide a barrier for somatic cell reprogramming. Nat Cell Biol.
13:1353–1360. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bouhallier F, Allioli N, Lavial F, Chalmel
F, Perrard MH, Durand P, Samarut J, Pain B and Rouault JP: Role of
miR-34c microRNA in the late steps of spermatogenesis. RNA.
16:720–731. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu WM, Pang RT, Chiu PC, Wong BP, Lao K,
Lee KF and Yeung WS: Sperm-borne microRNA-34c is required for the
first cleavage division in mouse. Proc Natl Acad Sci USA.
109:490–494. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Haramati S, Navon I, Issler O, Ezra-Nevo
G, Gil S, Zwang R, Hornstein E and Chen A: MicroRNA as repressors
of stress-induced anxiety: The case of amygdalar miR-34. J
Neurosci. 31:14191–14203. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Aranha MM, Santos DM, Solá S, Steer CJ and
Rodrigues CM: miR-34a regulates mouse neural stem cell
differentiation. PLoS One. 6:e213962011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Guan H, Zhu L, Fu M, Yang D, Tian S, Guo
Y, Cui C, Wang L and Jiang H: 3,3′Diindolylmethane suppresses
vascular smooth muscle cell phenotypic modulation and inhibits
neointima formation after carotid injury. PLoS One. 7:e349572012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hotchkiss A, Robinson J, MacLean J,
Feridooni T, Wafa K and Pasumarthi KB: Role of D-type cyclins in
heart development and disease. Can J Physiol Pharmacol.
90:1197–1207. 2012. View Article : Google Scholar : PubMed/NCBI
|
